수동 인공호흡기 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the manual resuscitator market size in 2026 is estimated at USD 678.04 million, growing from 2025 value of USD 638.52 million with 2031 projections showing USD 915.44 million, growing at 6.19% CAGR over 2026-2031.

This report is Segmented by Product Type (Self-Inflating Bags, Flow-Inflating Bags, T-Piece Resuscitators), Usage (Disposable, Reusable), Patient Type (Adult, Pediatric, Neonatal), Material (Silicone, and More), End User (Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Manual Resuscitator Market Trends and Insights

Growing Burden of COPD and Other Chronic Respiratory Diseases

Low- and middle-income nations carry the heaviest mortality load, hindered by limited screening and late intervention. Tobacco use explains 34.8% of COPD-related disability-adjusted life years, while ambient particulate matter accounts for 22.2%. Escalating respiratory emergencies across Asia-Pacific have moved manual resuscitators into essential bridge-therapy kits, especially for intra-facility transport. Acute exacerbations often outstrip mechanical ventilator availability, cementing the manual resuscitator market as a frontline solution.

Rising Incidence of Sudden Cardiac Arrest Requiring BVM Support

Roughly 356,000 Americans experience out-of-hospital cardiac arrest each year, with survival rates near 10%. The American Heart Association's 2030 target to lift bystander CPR rates above 50% implicitly raises demand for bag-valve-mask (BVM) devices that sustain oxygenation during the critical first minutes. United Kingdom ambulance services manage approximately 30,000 resuscitation attempts annually, achieving return-of-spontaneous-circulation in 30% of cases. Guidelines for athletic venues, where prompt ventilation assists neurological outcomes in young athletes, further broaden the manual resuscitator market. Pandemic-era infection-control measures boosted adoption of single-use resuscitators fitted with high-efficiency particulate air filters to protect rescuers.

Availability of Alternative Ventilation Solutions

High-flow nasal cannula systems and portable non-invasive ventilators provide oxygenation with lower aerosol risk, decreasing reliance on manual bags in some intensive-care algorithms. Mechanical chest-compression devices relieve rescuer fatigue but also shorten the window in which bag ventilation is prioritized. Wider placement of automated external defibrillators reorders the rescue sequence, potentially curbing first-line BVM use. Video laryngoscopes and supraglottic airways offer faster airway control, though manual resuscitators remain indispensable for pre-oxygenation and post-intubation support. Device makers therefore emphasize add-on features rather than raw volume growth to defend the manual resuscitator market.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing Geriatric Population and Home-Care Respiratory Demand
2. Steady Advancements in Integrated Pressure-Monitoring and PEEP Valves
3. Price Sensitivity in Low- and Middle-Income Markets

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Self-inflating bags controlled the largest slice of the manual resuscitator market in 2025 at 46.28%, owing to versatility and independence from gas outlets. T-piece devices, however, are positioned for the most rapid 8.28% CAGR through 2031, supported by evidence that they deliver steadier PEEP across variable lung compliance. Military medics and ambulance crews keep favoring self-inflating bags because of ruggedness and minimal setup. Yet tertiary hospitals increasingly specify T-piece systems for deliveries and pediatric intensive-care units, reflecting policy that demands lung-protective ventilation from the first breath.

Enhanced pressure control and sensor feedback spur premium pricing, which contributes to revenue expansion even as unit volumes stay balanced. Training curricula now incorporate simulations for both technologies, ensuring skill retention among clinicians and paramedics. These contrasting adoption patterns demonstrate why product diversity remains central to competitiveness within the manual resuscitator market.

Disposable units represented 55.78% of 2025 revenue and show the fastest 9.22% CAGR thanks to tightened infection-control rules after COVID-19. Hospitals cite reduced turnaround time and elimination of reprocessing error as prime benefits. Sterile packaging also permits field deployment without auxiliary clean-room supplies, appealing to military and humanitarian missions.

Reusable bags keep relevance in teaching labs and resource-constrained clinics where cost per use is decisive. Ambu's Mark IV, validated for 30 autoclave cycles, exemplifies value over multiyear horizons. The European Union now permits reprocessing of single-use devices under strict validation, creating a niche that straddles disposable and reusable categories. Even so, legal liability and traceability hurdles limit uptake, ensuring disposables retain growth leadership in the manual resuscitator market.

Complete Report Scope:

• By Product Type
  • Self-Inflating Bags
  • Flow-Inflating Bags
  • T-Piece Resuscitators
• By Usage
  • Disposable
  • Reusable
• By Patient Type
  • Adult
  • Pediatric
  • Neonatal
• By Material
  • Silicone
  • PVC
  • Rubber & Others
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America led with 37.95% revenue share in 2025 on the strength of advanced emergency medical services, extensive CPR training networks and sizeable defense procurement. Tactical Combat Casualty Care protocols credit manual ventilation with helping curb preventable battlefield deaths, which sustains steady military orders. Consistent funding permits hospitals to invest in sensor-enabled bags that streamline quality audits.

Asia-Pacific is poised for the most vigorous 8.71% CAGR to 2031 as China, India and Southeast Asian states fund trauma centers and pre-hospital care expansion. Public insurance schemes in China now reimburse neonatal resuscitation consumables, and India's Ayushman Bharat program allocates capital budgets for ambulance upgrades. In affluent markets such as Japan and South Korea, healthy aging policies spur procurement for home-care and long-term-care facilities, broadening exposure for the manual resuscitator market.

Europe maintains a mature but resilient trajectory. Pending 2026 rules that require recyclable packaging stir process innovation, while EU Medical Device Regulation 2017/745 opens a pathway for controlled reprocessing. Germany, United Kingdom and France drive volume, while Spain and Italy favor premium silicone models for neonatal wards. Latin America, the Middle East and Africa post mid-single-digit growth: Brazil's SAMU ambulance network and South Africa's urban EMS upgrades illustrate incremental gains, yet economic volatility and supply-chain constraints restrain faster penetration.

1. Ambu
2. Vyaire Medical
3. ICU Medical - Smiths Medical
4. Medtronic
5. Teleflex
6. Medline Industries
7. Intersurgical
8. Laerdal Medical
9. Mercury Medical
10. O-Two Medical Technologies
11. WEINMANN Emergency
12. HUM
13. Allied Healthcare Products
14. Resmed
15. Hopkins Medical Products
16. Besmed Health Business
17. Armstrong Medical
18. Airon
19. Parker Healthcare
20. GENTEC Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Burden of COPD & Other Chronic Respiratory Diseases
  • 4.2.2 Rising Incidence of Sudden Cardiac Arrest Requiring BVM Support
  • 4.2.3 Increasing Geriatric Population & Home-Care Respiratory Demand
  • 4.2.4 Steady Advancements in Integrated Pressure-Monitoring & PEEP Valves
  • 4.2.5 Post-COVID Infection-Control Shift Toward Single-Use Resuscitators
  • 4.2.6 Growing Adoption in Wilderness, Military & Veterinary Emergency Training
• 4.3 Market Restraints
  • 4.3.1 Availability of Alternative Ventilation Solutions
  • 4.3.2 Price Sensitivity in Low- & Middle-Income Markets
  • 4.3.3 Environmental Pushback Against Disposable Plastics & Upcoming EU MDR Documentation
  • 4.3.4 Skill-Gap & Inadequate Hands-On Training for Optimal BVM Use
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Bargaining Power of Suppliers
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

• 5.1 By Product Type
  • 5.1.1 Self-Inflating Bags
  • 5.1.2 Flow-Inflating Bags
  • 5.1.3 T-Piece Resuscitators
• 5.2 By Usage
  • 5.2.1 Disposable
  • 5.2.2 Reusable
• 5.3 By Patient Type
  • 5.3.1 Adult
  • 5.3.2 Pediatric
  • 5.3.3 Neonatal
• 5.4 By Material
  • 5.4.1 Silicone
  • 5.4.2 PVC
  • 5.4.3 Rubber & Others
• 5.5 By End User
  • 5.5.1 Hospitals
  • 5.5.2 Ambulatory Surgical Centers
  • 5.5.3 Speciality Clinics
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Ambu A/S
  • 6.3.2 Vyaire Medical Inc.
  • 6.3.3 ICU Medical - Smiths Medical
  • 6.3.4 Medtronic
  • 6.3.5 Teleflex Inc.
  • 6.3.6 Medline Industries LP
  • 6.3.7 Intersurgical Ltd
  • 6.3.8 Laerdal Medical
  • 6.3.9 Mercury Medical
  • 6.3.10 O-Two Medical Technologies
  • 6.3.11 WEINMANN Emergency
  • 6.3.12 HUM GmbH
  • 6.3.13 Allied Healthcare Products
  • 6.3.14 ResMed Inc.
  • 6.3.15 Hopkins Medical Products
  • 6.3.16 Besmed Health Business
  • 6.3.17 Armstrong Medical
  • 6.3.18 Airon Corporation
  • 6.3.19 Parker Healthcare
  • 6.3.20 GENTEC Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment